07:00 , May 2, 2016 |  BC Week In Review  |  Clinical News

Enstilar calcipotriene/betamethasone dipropionate aerosol foam regulatory update

The U.K. approved Leo’s Enstilar calcipotriene/ betamethasone foam spray to treat plaque psoriasis in adults. In March, Leo said Enstilar received a positive outcome under EU’s decentralized procedure (see BioCentury, April 11). The aerosol foam...
08:00 , Oct 30, 2006 |  BioCentury  |  Finance

Connetics chronicles

Connetics chronicles...
07:00 , Jul 24, 2006 |  BC Week In Review  |  Clinical News

Betamethasone Foam: Phase I/II data

In an Israeli Phase I/II trial in 30 patients comparing Foamix's Betamethasone foam with Betnovate cream, both compounds significantly improved psoriatic plaques versus baseline. The compounds were applied to different plaques on each patient, and...
02:19 , Mar 18, 2005 |  BC Extra  |  Financial News

Connetics raises $150M in note deal

CNCT raised $150 million in a bumped-up placing of convertible senior notes. The notes mature in 2015, bear 2% interest and convert into stock at $35.46, a 35% premium to CNCT's Thursday close of $26.27....
08:00 , Mar 8, 1999 |  BioCentury  |  Finance

Choppy waters

Small waves of optimism and pessimism are roiling the waters as another life science company stepped up to sell an IPO, while two NASDAQ IPOs have been put on ice, including cancer vaccine play...